To date, no other diseases associated with CCNF mutations have been identified, although elevated cyclin F expression levels have been correlated with poorer prognosis in patients with hepatocellular carcinoma [70], clear cell renal cell carcinoma [71], ovarian cancer [72], and breast cancer [73]. This evidence concerns the gene CCNF and breast cancer.